Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 17/20 | 0.71 |
| ▸ | ERBB2 | P04626 | 11/20 | 0.71 |
| ▸ | FECH | P22830 | 1/20 | 0.71 |
| ▸ | CDK8 | P49336 | 1/20 | 0.71 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.71 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.71 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.71 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174480 | 1.00 | EGFR (0.71) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6175434 | 0.93 | ERBB2 (0.82) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6175440 | 0.93 | ERBB2 (0.82) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6178275 | 0.92 | EGFR (0.75) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6178271 | 0.92 | EGFR (0.75) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL4618016 | 0.90 | EGFR (0.86) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL4618014 | 0.90 | EGFR (0.86) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6174132 | 0.89 | EGFR (0.74) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6175084 | 0.89 | EGFR (0.74) | EGFRERBB2FECHCDK8MAP2K5 | |
| SCHEMBL6174127 | 0.89 | EGFR (0.74) | EGFRERBB2FECHCDK8MAP2K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1292591-B1 | SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | PFIZER PROD INC (US) | 2005-02-02 | — | — | EP | disclosed |